MediciNova, Inc.
NASDAQ:MNOV
Overview | Financials
| Company Name | MediciNova, Inc. |
| Symbol | MNOV |
| Currency | USD |
| Price | 1.26 |
| Market Cap | 61,798,212 |
| Dividend Yield | 0% |
| 52-week-range | 1.13 - 2.55 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Dr. Yuichi Iwaki M.D., Ph.D. |
| Website | https://www.medicinova.com |
An error occurred while fetching data.
About MediciNova, Inc.
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD





